Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 67877-478

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 67877-478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole-1 (Esomeprazole 1)

A line graph titled 'Maintenance of Healing Rates by Month (Study 177)' showing percent maintained on the y-axis and months (0 to 6) on the x-axis. It compares healing rates over time among four groups: Esomeprazole 40 mg, Esomeprazole 20 mg, Esomeprazole 10 mg, and placebo, each represented by different line styles and markers.*

FDA Label Image

Esomeprazole-20mg-30s (Esomeprazole 20mg 30s)

Label for Esomeprazole Magnesium Delayed-Release Capsules USP 20 mg by Ascend Laboratories, LLC. The label states capsule strength and instructs to dispense the accompanying medication guide. It includes storage information, manufacturer Alkem Laboratories Ltd. in India, distributor Ascend Laboratories, LLC in NJ, and packaging for 30 capsules. The label also features barcodes and handling instructions.*

FDA Label Image

Esomeprazole-40mg-30s (Esomeprazole 40mg 30s)

Label for Esomeprazole Magnesium 40 mg delayed-release capsules by Ascend Laboratories, LLC. The label includes storage instructions, manufacturer Alkem Laboratories, and distributor information for Ascend Laboratories, LLC. It specifies the dosage form as capsules and package count as 30.*

FDA Label Image

Esomeprazole-pic-2 (Esomeprazole Pic 2)

A line graph titled 'Maintenance of Healing Rates by Month (Study 178)' showing the percent maintained on the y-axis and months on the x-axis. It compares healing rates over six months for esomeprazole 40 mg, 20 mg, 10 mg, and placebo groups. The 40 mg group maintains near 100% healing, while lower doses and placebo show decreased maintenance over time.*

FDA Label Image

Esomeprazole-pic-3 (Esomeprazole Pic 3)

A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 225)' showing the percentage of patients without heartburn over 28 days. The x-axis represents Diary Day from 0 to 28, and the y-axis represents Percent of Patients Symptom-Free from 0 to 100. Three lines compare Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo, with higher symptom-free percentages observed for both Esomeprazole doses compared to placebo.*

FDA Label Image

Esomeprazole-pic-4 (Esomeprazole Pic 4)

A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 226)' showing three lines representing Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The y-axis indicates percent of patients symptom-free from 0 to 100%, and the x-axis shows days from 0 to 28.*

FDA Label Image

Esomeprazole-str-1 (Esomeprazole Str 1)

Chemical structure of esomeprazole magnesium, depicting its molecular arrangement including heterocyclic rings, oxygen and nitrogen atoms, methyl and methoxy groups, and magnesium ion complexation with water molecules as shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.